Jonathan Sheena - 20 Jan 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director, CO-FOUNDER
Signature
/s/ Tami Chen, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
20 Jan 2025
Transactions value $
-$160,214
Form type
4
Filing time
22 Jan 2025, 21:45:12 UTC
Previous filing
21 Jan 2025
Next filing
29 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise +191 +0.07% 263K 20 Jan 2025 Direct F1
transaction NTRA Common Stock Options Exercise +144 +0.05% 263K 21 Jan 2025 Direct F1
transaction NTRA Common Stock Sale -$159K -964 -0.37% $164.95 262K 22 Jan 2025 Direct F2
transaction NTRA Common Stock Sale -$1.2K -7 0% $171.91 262K 22 Jan 2025 Direct F2, F3
holding NTRA Common Stock 44.8K 20 Jan 2025 By Caraluna 1 Trust F4
holding NTRA Common Stock 44.8K 20 Jan 2025 By Caraluna 2 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -191 -20.06% $0.00 761 20 Jan 2025 Common Stock 191 Direct F1, F5
transaction NTRA Restricted Stock Unit Options Exercise $0 -144 -100% $0.00 0 21 Jan 2025 Common Stock 144 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.9160 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
F5 The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
F6 The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter